Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Estramustine, Etoposide and Paclitaxel Treatment for Hormonally Responsive Adenocarcinoma of the Prostate

This study has been completed.
Information provided by (Responsible Party):
University of Michigan Cancer Center Identifier:
First received: September 6, 2005
Last updated: January 19, 2015
Last verified: January 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2006
  Primary Completion Date: November 2004 (Final data collection date for primary outcome measure)